Literature DB >> 15926936

Decreased firing frequency of midbrain dopamine neurons in mice lacking mu opioid receptors.

Daniel S Mathon1, Geert M J Ramakers, John E Pintar, Michela Marinelli.   

Abstract

Dopamine neurons originating in the midbrain and projecting to cortico-limbic and motor structures are one of the major neuronal substrates implicated in the reinforcing properties of drugs of abuse. The output of this system is largely determined by its impulse activity (amount and pattern of firing activity). Several intrinsic and synaptic factors can influence dopamine neuronal activity and, consequently, addiction liability. Pharmacological studies indicate that mu-opioid receptors and their activation by endogenous opioids may play an important role. In the present study, we use a genetic approach to better understand the role of mu-opioid receptors in modulating dopamine neuronal activity in vivo. Using in vivo extracellular single-unit recordings, we show that mice lacking mu-opioid receptors exhibit lower firing rates of dopamine neurons compared with their wild-type littermates. Although we observed no overall changes in bursting activity compared with wild-type mice, animals lacking mu-opioid receptors exhibited a higher proportion of regular-spiking cells that lacked bursting activity. These findings are the first to emphasize the critical role of mu-opioid receptors in modulating action potential output of dopamine neurons in vivo using a genetic approach. They also provide a possible underlying mechanism for the decreased reinforcing properties of drugs of abuse that was previously observed in mice lacking mu-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15926936     DOI: 10.1111/j.1460-9568.2005.04123.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

1.  Blunted opiate modulation of prolactin response in smoking men and women.

Authors:  Darcy Shaw; Mustafa al'Absi
Journal:  Pharmacol Biochem Behav       Date:  2009-12-05       Impact factor: 3.533

2.  Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms.

Authors:  V I Chefer; L Denoroy; A Zapata; T S Shippenberg
Journal:  Eur J Neurosci       Date:  2009-07-15       Impact factor: 3.386

Review 3.  Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?

Authors:  F Scott Hall; Jana Drgonova; Siddharth Jain; George R Uhl
Journal:  Pharmacol Ther       Date:  2013-07-18       Impact factor: 12.310

4.  Long-lasting alteration in mesocorticolimbic structures after repeated social defeat stress in rats: time course of mu-opioid receptor mRNA and FosB/DeltaFosB immunoreactivity.

Authors:  Ella M Nikulina; Isabel Arrillaga-Romany; Klaus A Miczek; Ronald P Hammer
Journal:  Eur J Neurosci       Date:  2008-05       Impact factor: 3.386

5.  ProSAAS-derived peptides are regulated by cocaine and are required for sensitization to the locomotor effects of cocaine.

Authors:  Iryna Berezniuk; Ramona M Rodriguiz; Michael L Zee; David J Marcus; John Pintar; Daniel J Morgan; William C Wetsel; Lloyd D Fricker
Journal:  J Neurochem       Date:  2017-11       Impact factor: 5.372

6.  Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans.

Authors:  Mary R Lee; Courtney L Gallen; Xiaochu Zhang; Colin A Hodgkinson; David Goldman; Elliot A Stein; Christina S Barr
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

7.  Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people.

Authors:  Victoria C Cambridge; Hisham Ziauddeen; Pradeep J Nathan; Naresh Subramaniam; Chris Dodds; Samuel R Chamberlain; Annelize Koch; Kay Maltby; Andrew L Skeggs; Antonella Napolitano; I Sadaf Farooqi; Edward T Bullmore; Paul C Fletcher
Journal:  Biol Psychiatry       Date:  2012-12-14       Impact factor: 13.382

8.  Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements.

Authors:  Collin B Merrill; Lindsey N Friend; Scott T Newton; Zachary H Hopkins; Jeffrey G Edwards
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.